Synergic Effects of EPI-NCSCs and OECs on the Donor Cells Migration , the Expression of Neurotrophic Factors , and Locomotor Recovery of Contused Spinal Cord of Rats Jieyuan Zhang & Zheng Liu & Huijun Chen & Zhaoxia Duan & Lu Zhang & Lizhao Chen & Bingcang Li Abstract Cell-based therapy	1
Synergic Effects	1
EPI-NCSCs and OECs on the Donor Cells Migration , the Expression of Neurotrophic Factors , and Locomotor Recovery of Contused Spinal Cord of Rats Jieyuan Zhang & Zheng Liu & Huijun Chen & Zhaoxia Duan & Lu Zhang & Lizhao Chen & Bingcang Li Abstract Cell-based therapy	21
EPI-NCSCs and OECs on the Donor Cells Migration	21
EPI-NCSCs and OECs	21
the Donor Cells Migration	43
the Expression of Neurotrophic Factors	70
the Expression	70
Neurotrophic Factors	88
Locomotor Recovery of Contused Spinal Cord of Rats Jieyuan Zhang & Zheng Liu & Huijun Chen & Zhaoxia Duan & Lu Zhang & Lizhao Chen & Bingcang Li Abstract Cell-based therapy	114
Locomotor Recovery	114
Contused Spinal Cord of Rats Jieyuan Zhang & Zheng Liu & Huijun Chen & Zhaoxia Duan & Lu Zhang & Lizhao Chen & Bingcang Li Abstract Cell-based therapy	136
Contused Spinal Cord	136
Rats Jieyuan Zhang & Zheng Liu & Huijun Chen & Zhaoxia Duan & Lu Zhang & Lizhao Chen & Bingcang Li Abstract Cell-based therapy	160
a promising strategy for the repair of spinal cord injury -LRB- SCI -RRB-	292
a promising strategy	292
the repair of spinal cord injury -LRB- SCI -RRB-	317
the repair	317
spinal cord injury -LRB- SCI -RRB-	331
spinal cord injury	331
SCI	351
the synergic effects of donor cells	361
the synergic effects	361
donor cells	385
recent years	415
this study	432
epidermal neural crest stem cells -LRB- EPI-NCSCs -RRB- and olfactory ensheathing cells -LRB- OECs -RRB-	444
epidermal neural crest stem cells -LRB- EPI-NCSCs -RRB-	444
epidermal neural crest stem cells	444
EPI-NCSCs	479
olfactory ensheathing cells -LRB- OECs -RRB-	494
olfactory ensheathing cells	494
OECs	523
the contused spinal cord of rats separately or jointly at 1 week	552
spinal cord of rats	565
spinal cord	565
rats	580
1	610
injury	623
3 and 9 weeks posttransplantation	634
3 and 9 weeks	634
posttransplantation	648
migration of the donor cells , expression of brain-derived neurotrophic factor -LRB- BDNF -RRB- and glial cell line-derived neurotrophic factor -LRB- GDNF -RRB- and functional recovery of the contused cord	669
migration of the donor cells	669
migration	669
the donor cells	682
expression of brain-derived neurotrophic factor -LRB- BDNF -RRB-	699
expression	699
brain-derived neurotrophic factor	713
BDNF	748
glial cell line-derived neurotrophic factor -LRB- GDNF -RRB- and functional recovery of the contused cord	758
glial cell line-derived neurotrophic factor -LRB- GDNF -RRB-	758
glial cell	758
line-derived neurotrophic factor -LRB- GDNF -RRB-	769
line-derived neurotrophic factor	769
GDNF	803
functional recovery of the contused cord	813
functional recovery	813
the contused cord	836
the	836
cord	849
techniques of histopathology , quantitative real-time polymerase chain reaction -LRB- qPCR -RRB- , immunohistochemistry and Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- score	873
techniques	873
histopathology , quantitative real-time polymerase chain reaction -LRB- qPCR -RRB- , immunohistochemistry and Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- score	887
histopathology	887
quantitative real-time polymerase chain reaction -LRB- qPCR -RRB- , immunohistochemistry and Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- score	903
quantitative real-time polymerase chain reaction	903
quantitative real-time polymerase	903
chain reaction	937
qPCR	953
immunohistochemistry	960
Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- score	985
Basso -- Beattie -- Bresnahan -LRB- BBB -RRB-	985
Basso -- Beattie -- Bresnahan	985
Beattie	991
BBB	1010
score	1015
The results	1022
themigration and distribution of EPI-NCSCs in vivo	1046
themigration and distribution	1046
EPI-NCSCs in vivo	1079
EPI-NCSCs	1079
vivo	1092
OECs at 3 weeks	1114
OECs	1114
3 weeks	1122
transplantation	1136
they	1157
9 weeks	1174
The expression of BDNF and GDNF	1183
The expression	1183
BDNF and GDNF	1201
co-transplantation	1246
molecular and protein level	1268
molecular	1268
protein level	1282
the expression of both factors in EPI-NCSCs - and OECs-injected group	1306
the expression	1306
both factors in EPI-NCSCs - and OECs-injected group	1324
both factors	1324
EPI-NCSCs	1340
OECs-injected group	1355
coinjected group	1393
it	1411
control groups	1433
the best locomotor recovery of the contused cordwas	1460
the best locomotor recovery	1460
the contused cordwas	1491
co-injected animals	1526
we	1550
this	1559
the first time to study the synergic effects of EPI-NCSCs and OECs	1567
the synergic effects of EPI-NCSCs and OECs	1591
the synergic effects	1591
EPI-NCSCs and OECs	1615
the data	1639
donor cells migration , expression of neurotrophic factors -LRB- NTFs -RRB- , and recovery of motor function	1663
donor cells migration	1663
donor cells	1663
migration	1675
expression of neurotrophic factors -LRB- NTFs -RRB-	1686
expression	1686
neurotrophic factors -LRB- NTFs -RRB-	1700
neurotrophic factors	1700
NTFs	1722
recovery of motor function	1733
recovery	1733
motor function	1745
EPI-NCSCs and OECs	1779
Introduction Spinal cord injury -LRB- SCI -RRB-	1816
Introduction Spinal cord injury	1816
Introduction	1816
Spinal cord injury	1829
SCI	1849
complex pathophysiological processes which result in complete or partial loss of sensation and mobility and affect the life qualities of patients	1864
complex pathophysiological processes	1864
complete or partial loss of sensation and mobility	1917
complete or partial loss	1917
sensation and mobility	1945
the life qualities of patients	1979
the life qualities	1979
patients	2001
recent years	2014
many laboratories	2028
cell transplantation	2065
a perspective strategy for treating SCI	2089
a perspective strategy	2089
SCI	2125
SCI	2140
cell transplantation into the lesion site	2145
cell transplantation	2145
the lesion site	2171
permissive substrates	2211
nerve cell	2248
apoptosis	2271
remyelination	2292
cascade effect of inflammatory reaction -LRB- Antonic et al. 2013 ; Cui et al. 2013 ; Li et al. 2013 -RRB-	2320
cascade effect	2320
inflammatory reaction -LRB- Antonic et al. 2013 ; Cui et al. 2013 ; Li et al. 2013 -RRB-	2338
inflammatory reaction	2338
Antonic et al. 2013 ; Cui et al. 2013 ; Li et al. 2013	2361
Antonic et al. 2013 ; Cui et al. 2013 ; Li et al.	2361
et al. 2013 ; Cui et al. 2013 ; Li et al.	2369
et al. 2013	2369
et al.	2369
2013	2376
Cui et al. 2013	2382
Cui	2382
et al.	2386
2013	2393
Li et al.	2399
Li	2399
et al.	2402
2013	2409
Different cell types , including olfactory ensheathing cells -LRB- OECs -RRB- , Schwann cells -LRB- SCs -RRB- , neural stemcells -LRB- NSCs -RRB- , and marrow stroma cells -LRB- MSCs -RRB-	2416
Different cell types	2416
olfactory ensheathing cells -LRB- OECs -RRB- , Schwann cells -LRB- SCs -RRB- , neural stemcells -LRB- NSCs -RRB- , and marrow stroma cells -LRB- MSCs -RRB-	2448
olfactory ensheathing cells -LRB- OECs -RRB-	2448
olfactory ensheathing cells	2448
OECs	2477
Schwann cells -LRB- SCs -RRB-	2484
Schwann cells	2484
SCs	2499
neural stemcells -LRB- NSCs -RRB-	2505
neural stemcells	2505
NSCs	2523
marrow stroma cells -LRB- MSCs -RRB-	2534
marrow stroma cells	2534
MSCs	2555
donor cells for transplantation	2579
donor cells	2579
transplantation	2595
SCI	2617
variable degrees of success -LRB- Hooshmand et al. 2009 ; Quertainmont et al. 2012 ; Wang et al. 2012 ; Mayeur et al. 2013 -RRB-	2626
variable degrees	2626
success -LRB- Hooshmand et al. 2009 ; Quertainmont et al. 2012 ; Wang et al. 2012 ; Mayeur et al. 2013 -RRB-	2646
success	2646
Hooshmand	2655
et al. 2009 ; Quertainmont et al. 2012 ; Wang et al. 2012 ; Mayeur et al. 2013	2665
et al. 2009 ; Quertainmont et al. 2012 ; Wang et al. 2012 ; Mayeur et al.	2665
et al. 2009	2665
et al.	2665
2009	2672
Quertainmont et al. 2012	2678
Quertainmont	2678
et al.	2691
2012	2698
Wang et al. 2012	2704
Wang	2704
et al.	2709
2012	2716
Mayeur et al.	2722
Mayeur	2722
et al.	2729
2013	2736
Epidermal neural crest stem cells -LRB- EPI-NCSCs -RRB- , derived from the embryonic neural crest ,	2743
Epidermal neural crest stem cells -LRB- EPI-NCSCs -RRB-	2743
Epidermal neural crest stem cells	2743
EPI-NCSCs	2778
the embryonic neural crest	2803
a strong candidate for cell - based therapy	2834
a strong candidate	2834
cell	2857
therapy	2869
they	2886
the advantages of embryonic stemcells and adult stem cells	2899
the advantages	2899
embryonic stemcells and adult stem cells	2917
embryonic stemcells	2917
adult stem cells	2941
EPI-NCSCs transplantation	2959
an attractive strategy for causing a significant improvement in sensory connectivity and touch perception following SCI , by expressing neurotrophic factors , angiogenic factors and extracellular proteases , which in combination have the capability of supporting cell survival , neovascularization and modulation of scar formation -LRB- Pandamooz et al. 2013 -RRB-	2988
an attractive strategy	2988
a significant improvement	3023
sensory connectivity and touch perception following SCI	3052
sensory connectivity and touch perception	3052
SCI	3104
neurotrophic factors , angiogenic factors and extracellular proteases , which in combination have the capability of supporting cell survival , neovascularization and modulation of scar formation -LRB- Pandamooz et al. 2013 -RRB-	3123
neurotrophic factors , angiogenic factors and extracellular proteases	3123
neurotrophic factors	3123
angiogenic factors	3145
extracellular proteases	3168
combination	3202
the capability of supporting cell survival , neovascularization and modulation of scar formation -LRB- Pandamooz et al. 2013 -RRB-	3219
the capability	3219
cell survival , neovascularization and modulation of scar formation -LRB- Pandamooz et al. 2013 -RRB-	3248
cell survival	3248
neovascularization and modulation of scar formation -LRB- Pandamooz et al. 2013 -RRB-	3263
neovascularization and modulation	3263
scar formation -LRB- Pandamooz et al. 2013 -RRB-	3300
scar formation	3300
Pandamooz et al. 2013	3316
Pandamooz	3316
et al. 2013	3326
et al.	3326
2013	3333
the poor migration of grafted EPI-NCSCs in the injured cord	3349
the poor migration	3349
grafted EPI-NCSCs in the injured cord	3371
grafted EPI-NCSCs	3371
the injured cord	3392
a major challenge -LRB- Sieber-Blum et al. 2006 -RRB-	3417
a major challenge	3417
Sieber-Blum et al. 2006	3436
Sieber-Blum	3436
et al. 2006	3448
et al.	3448
2006	3455
OECs	3462
a central role in the repair of SCI	3472
a central role	3472
the repair of SCI	3490
the repair	3490
SCI	3504
their abundant production of growth-promoting factors and cell adhesion molecules	3515
their abundant production	3515
growth-promoting factors and cell adhesion molecules	3544
OECs	3598
functional recovery via increase of the survival number of NSCs and axonal regeneration in vivo -LRB- Shukla et al. 2009 -RRB-	3633
functional recovery	3633
increase of the survival number of NSCs and axonal regeneration in vivo	3657
increase	3657
the survival number of NSCs and axonal regeneration in vivo	3669
the survival number of NSCs	3669
the survival number	3669
NSCs	3692
axonal regeneration in vivo	3701
axonal regeneration	3701
vivo	3724
Shukla	3730
et al. 2009	3737
et al.	3737
2009	3744
OECs	3761
a source of trophic factors , including nerve growth factor -LRB- NGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- , glial cell-derived neurotrophic factor -LRB- GDNF -RRB- , and ciliary neurotrophic factor -LRB- CNTF -RRB-	3770
a source	3770
trophic factors	3782
nerve growth factor -LRB- NGF -RRB- , brain-derived neurotrophic factor -LRB- BDNF -RRB- , glial cell-derived neurotrophic factor -LRB- GDNF -RRB- , and ciliary neurotrophic factor -LRB- CNTF -RRB-	3809
nerve growth factor -LRB- NGF -RRB-	3809
nerve growth factor	3809
NGF	3830
brain-derived neurotrophic factor -LRB- BDNF -RRB-	3836
brain-derived neurotrophic factor	3836
BDNF	3871
glial cell-derived neurotrophic factor -LRB- GDNF -RRB-	3878
glial cell-derived neurotrophic factor	3878
GDNF	3918
ciliary neurotrophic factor -LRB- CNTF -RRB-	3929
ciliary neurotrophic factor	3929
CNTF	3958
They	3965
their environment in virtue of these trophic molecules -LRB- Radtke and Kocsis 2012 -RRB-	3987
their environment	3987
virtue of these trophic molecules -LRB- Radtke and Kocsis 2012 -RRB-	4008
virtue	4008
these trophic molecules -LRB- Radtke and Kocsis 2012 -RRB-	4018
these trophic molecules	4018
Radtke and Kocsis 2012	4043
Radtke	4043
Kocsis 2012	4054
migration of OECs in the injured spinal cord	4081
migration	4081
OECs in the injured spinal cord	4094
OECs	4094
the injured spinal cord	4102
they	4144
less astrocyte response in vitro and in vivo	4156
less astrocyte response	4156
vivo	4196
astrocyte	4217
injection -LRB- Santos-Silva et al. 2007 ; Li et al. 2012 -RRB-	4233
injection	4233
Santos-Silva	4244
et al. 2007 ; Li et al. 2012	4257
et al. 2007 ; Li et al.	4257
et al. 2007	4257
et al.	4257
2007	4264
Li et al.	4270
Li	4270
et al.	4273
2012	4280
it	4297
combination of two kinds of cells	4317
combination	4317
two kinds of cells	4332
two kinds	4332
cells	4345
the synergistic effects	4361
repair of SCI -LRB- Ban et al. 2011 ; Gerin et al. 2011 -RRB-	4388
repair	4388
SCI -LRB- Ban et al. 2011 ; Gerin et al. 2011 -RRB-	4398
SCI	4398
Ban	4403
et al. 2011 ; Gerin et al. 2011	4407
et al. 2011 ; Gerin et al.	4407
et al. 2011	4407
et al.	4407
2011	4414
Gerin et al.	4420
Gerin	4420
et al.	4426
2011	4433
the present study	4443
EPINCSCs and OECs	4462
the contused spinal cord separately or jointly at 1 week	4503
spinal cord	4516
1	4553
injury for determining whether OECs promote EPI-NCSCs migration	4566
injury	4566
OECs	4597
EPI-NCSCs migration	4610
their synergistic effects	4635
the expression of BDNF and GDNF and the recovery of motor function of a clinically relevant model of the contusive SCI	4664
the expression of BDNF and GDNF	4664
the expression	4664
BDNF and GDNF	4682
the recovery of motor function of a clinically relevant model of the contusive SCI	4700
the recovery	4700
motor function of a clinically relevant model of the contusive SCI	4716
motor function	4716
a clinically relevant model of the contusive SCI	4734
a clinically relevant model	4734
the contusive SCI	4765
Materials and Methods Preparation of EPI-NCSCs EPI-NCSCs	4785
Materials	4785
Methods Preparation of EPI-NCSCs EPI-NCSCs	4799
Methods Preparation	4799
EPI-NCSCs EPI-NCSCs	4822
whisker follicles of adult green fluorescence protein -LRB- GFP -RRB- rat according to the previous description -LRB- Sieber-Blum and Hu 2008 ; Zhang et al. 2012 -RRB-	4861
whisker follicles	4861
adult green fluorescence protein -LRB- GFP -RRB- rat according to the previous description -LRB- Sieber-Blum and Hu 2008 ; Zhang et al. 2012 -RRB-	4882
adult green fluorescence protein -LRB- GFP -RRB- rat	4882
GFP	4916
the previous description	4938
Sieber-Blum and Hu 2008 ; Zhang et al. 2012	4964
Sieber-Blum and Hu 2008 ; Zhang et al.	4964
Sieber-Blum and Hu 2008	4964
Sieber-Blum	4964
Hu 2008	4980
Zhang et al.	4989
Zhang	4989
et al.	4995
2012	5002
whisker follicles	5017
adult GFP transgenic rats	5055
adult GFP	5055
transgenic rats	5065
Tissue	5082
cavernous sinus and ring sinus	5160
The bulges	5192
the capsule	5222
collagen-coated culture plates	5250
they	5287
the substratum	5303
30 min	5325
the culture medium	5338
85 %	5370
Dulbecco ' sModified Eagle ' sMedium -LRB- DMEM -RRB-	5373
Dulbecco '	5373
sModified Eagle ' sMedium -LRB- DMEM -RRB-	5382
sModified Eagle ' sMedium	5382
sModified Eagle '	5382
DMEM	5406
F12	5412
10 %	5417
fetal calf serum , 2 % B27 -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5421
fetal calf serum	5421
2 % B27 -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5439
2 % B27	5439
all from Gibco	5448
all	5448
Gibco	5457
Grand Island , NY , USA	5464
Grand Island	5464
NY , USA	5478
10 ng/ml of basic fibroblast growth factor -LRB- bFGF , Sigma-Aldrich , St. Louis , MO , USA -RRB-	5492
10 ng/ml	5492
basic fibroblast growth factor -LRB- bFGF , Sigma-Aldrich , St. Louis , MO , USA -RRB-	5504
basic fibroblast growth factor	5504
bFGF , Sigma-Aldrich , St. Louis , MO , USA	5536
bFGF	5536
Sigma-Aldrich	5542
St. Louis	5557
MO	5568
USA	5572
the third day	5591
cells	5606
the bulge explants	5637
the culture substratum	5661
the bulges	5697
the adhering cells	5725
trypsin -LRB- Gibco , Grand Island , NY , USA -RRB- treatment	5756
trypsin -LRB- Gibco , Grand Island , NY , USA -RRB-	5756
trypsin	5756
Gibco	5765
Grand Island	5772
NY , USA	5786
treatment	5795
It	5835
these cells	5869
a pure population of EPI-NCSCs confirmed by the immunohistochemistry staining of nestin , SOX10 , and β-III tubulin antibody -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5892
a pure population	5892
EPI-NCSCs confirmed by the immunohistochemistry staining of nestin , SOX10 , and β-III tubulin antibody -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5913
EPI-NCSCs	5913
the immunohistochemistry staining of nestin , SOX10 , and β-III tubulin antibody -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5936
the immunohistochemistry staining	5936
nestin , SOX10 , and β-III tubulin antibody -LRB- all from Gibco , Grand Island , NY , USA -RRB-	5973
nestin	5973
SOX10	5981
β-III tubulin antibody	5992
all from Gibco	6016
all	6016
Gibco	6025
Grand Island , NY , USA	6032
Grand Island	6032
NY , USA	6046
The suspension	6056
the concentration of 1.0 × 105/ul for transplantation	6101
the concentration	6101
1.0 × 105/ul for transplantation	6122
1.0 × 105/ul	6122
transplantation	6137
Preparation of OECs OECs	6154
Preparation	6154
OECs OECs	6169
the olfactory bulbs of adult GFP rats as described previously -LRB- Sasaki et al. 2004 ; Li et al. 2012 -RRB-	6199
the olfactory bulbs	6199
adult GFP rats as described previously -LRB- Sasaki et al. 2004 ; Li et al. 2012 -RRB-	6222
adult GFP rats	6222
Sasaki	6262
et al. 2004 ; Li et al. 2012	6269
et al. 2004 ; Li et al.	6269
et al. 2004	6269
et al.	6269
2004	6276
Li et al.	6282
Li	6282
et al.	6285
2012	6292
the olfactory bulbs removed from adult GFP rats	6308
the olfactory bulbs	6308
adult GFP rats	6341
meninges and white matter	6379
meninges	6379
white matter	6392
scalpel blades	6418
25 min in trypsin	6452
25 min	6452
trypsin	6462
37 °C within the CO2 incubator	6473
37 °C	6473
the CO2 incubator	6486
tissue	6510
a very gentle mechanical trituration	6538
a culture flask in DMEM/F12 medium with 10 % fetal calf serum , 10 ng/ml bFGF , and 2 uM Forskolin -LRB- Sigma-Aldrich , St. Louis , MO , USA -RRB-	6598
a culture flask	6598
DMEM/F12 medium	6617
10 % fetal calf serum	6638
10 ng/ml bFGF	6661
2 uM Forskolin -LRB- Sigma-Aldrich , St. Louis , MO , USA -RRB-	6680
2 uM Forskolin	6680
Sigma-Aldrich	6696
St. Louis	6711
MO , USA	6722
5 -- 7 days	6738
5	6738
7 days	6740
antibody staining	6748
at least 95 % of donor cells	6791
at least 95 %	6791
donor cells	6808
both P75 -LRB- 1:200 dilution -RRB- and S-100 -LRB- 1:500 dilution ; all from Abcam , Cambridge , MA , USA -RRB-	6825
both P75 -LRB- 1:200 dilution -RRB-	6825
both P75	6825
1:200 dilution	6835
S-100 -LRB- 1:500 dilution ; all from Abcam , Cambridge , MA , USA -RRB-	6855
S-100	6855
1:500 dilution ; all from Abcam , Cambridge , MA , USA	6862
1:500 dilution	6862
all from Abcam , Cambridge , MA , USA	6878
all from Abcam , Cambridge , MA ,	6878
all	6878
Abcam , Cambridge , MA ,	6887
USA	6909
The suspension	6924
the concentration of 1.0 × 105/ul for transplantation	6969
the concentration	6969
1.0 × 105/ul for transplantation	6990
1.0 × 105/ul	6990
transplantation	7005
Spinal Cord Injury and Animal Groups Adult male Sprague Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB- were housed according to the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and postop care	7022
Spinal Cord	7022
Injury and Animal Groups Adult male Sprague Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB-	7034
Injury and Animal Groups Adult male Sprague Dawley -LRB- SD -RRB- rats	7034
Injury and Animal Groups	7034
Adult male Sprague Dawley -LRB- SD -RRB- rats	7059
SD	7086
200 -- 250 g	7096
200	7096
250 g	7100
the Third Military Medical University -LRB- TMMU -RRB- guidelines , and surgical procedures and postop care	7132
the Third Military Medical University -LRB- TMMU -RRB- guidelines	7132
TMMU	7171
surgical procedures and postop care	7193
surgical procedures	7193
postop care	7217
accordance	7247
protocols approved by TMMU Institutional Animal Care and Use Committee	7263
protocols	7263
TMMU Institutional Animal Care and Use Committee	7285
Rats	7335
a single intraperitoneal injection of 1 % pentobarbital -LRB- 30 mg/kg -RRB-	7363
a single intraperitoneal injection	7363
1 % pentobarbital -LRB- 30 mg/kg -RRB-	7401
1 % pentobarbital	7401
30 mg/kg	7420
a sterile laminectomy	7435
vertebral levels T10	7474
The spinal cords	7496
an NYU II impactor with a dropping weight	7533
an NYU II impactor	7533
a dropping weight	7557
10.0 g from 25 mm above the exposed cord	7575
10.0 g	7575
25 mm above the exposed cord	7587
25 mm	7587
the exposed cord	7599
injury	7623
the muscle and skin	7631
layers	7666
The procedure	7674
hind limb paralysis	7700
all animals	7723
some of them	7740
some	7740
them	7748
hematuria and urinary retention	7762
hematuria	7762
urinary retention	7776
the infections	7806
Bicillin -LRB- 60,000 U/kg , i.m. -RRB-	7822
Bicillin	7822
60,000 U/kg , i.m.	7832
60,000 U/kg	7832
i.m.	7845
7 days with bladder expression	7871
7 days	7871
bladder expression	7883
twice a day	7902
recovery of the urinate function	7920
recovery	7920
the urinate function	7932
The contused rats	7954
five groups -LRB- n = 20/group -RRB-	7999
five groups	7999
n = 20/group	8012
n	8012
= 20/group	8013
Group A	8025
the blank control	8037
transplantation	8063
Group B	8080
6 ul DMEM/F12	8104
Groups C , D , and E	8119
Groups	8119
C , D , and E	8126
6 ul suspension of EPI-NCSCs , OECs , and mixed EPI-NCSCs-OECs	8161
6 ul suspension	8161
EPI-NCSCs , OECs , and mixed EPI-NCSCs-OECs	8180
EPI-NCSCs	8180
OECs	8191
mixed EPI-NCSCs-OECs	8201
day 7 after injury	8240
day 7	8240
injury	8252
Cell Transplantation The transplantation	8260
Cell Transplantation	8260
The transplantation	8281
day 7	8318
spinal cord injury	8330
The rats	8350
the laminectomy site	8396
Two microliters of cell suspension	8433
Two microliters	8433
cell suspension	8452
the midline of the contused cord at a depth of 0.8 mm at the epicenter of the lesion , and at 1 mm rostral and caudal to the epicenter	8488
the midline	8488
the contused cord at a depth of 0.8 mm at the epicenter of the lesion , and at 1 mm rostral and caudal to the epicenter	8503
the	8503
cord	8516
a depth of 0.8 mm at the epicenter of the lesion , and at 1 mm rostral and caudal	8524
a depth	8524
0.8 mm at the epicenter of the lesion , and at 1 mm rostral and caudal	8535
0.8 mm	8535
the epicenter of the lesion	8545
the epicenter	8545
the lesion	8562
1 mm rostral and caudal	8581
1 mm rostral	8581
caudal	8598
the epicenter	8608
a total of 6 μl of cell suspension	8623
a total	8623
6 μl of cell suspension	8634
6 μl	8634
cell suspension	8642
The cell injections	8668
a 5-ul Hamilton syringe , which remained in place for 5 min after each injection	8709
a 5-ul Hamilton syringe	8709
place for 5 min	8752
place	8752
5 min	8762
each injection	8774
The control animals	8790
identical volumes of DMEM/F12	8827
identical volumes	8827
DMEM/F12	8848
the same sites	8860
the injection	8882
the muscle and skin	8897
interrupted sutures	8934
CyclosporinA -LRB- 10 mg/kg , i.m. -RRB-	8955
CyclosporinA	8955
10 mg/kg , i.m.	8969
10 mg/kg	8969
i.m.	8979
euthanasia	9007
Immunofluorescent Staining and Measurement	9019
the Donor Cells	9065
Three and 9 weeks posttransplantation	9081
Three and 9 weeks	9081
posttransplantation	9099
the rat spinal cord	9120
4 % paraformaldehyde	9168
the same fixative for 24 h	9206
the same fixative	9206
24 h	9228
20 % sucrose	9254
48 h. Segments of the spinal cord	9271
48 h. Segments	9271
the spinal cord	9289
the T9 and T11	9314
optimal cutting temperature compound -LRB- OCT , Boster , Wuhan , China -RRB-	9347
optimal cutting temperature compound	9347
OCT	9385
Boster	9390
Wuhan , China	9398
a cryostat -LRB- LEICA CM-1900 , GE -RRB-	9438
a cryostat	9438
LEICA CM-1900	9450
GE	9465
serial	9474
15-μm-thick sagittal frozen sections	9481
The frozen slides	9519
air dried at room temperature for 10 min and washed with PBS for 10 min	9542
air	9542
room temperature	9555
10 min	9576
PBS for 10 min	9599
PBS	9599
10 min	9607
they	9620
3 % bovine serum albumin -LRB- BSA -RRB-	9643
3 % bovine serum albumin	9643
3 %	9643
BSA	9669
0.3 % Triton X-100 for 1 h	9685
0.3 % Triton X-100	9685
1 h	9707
room temperature	9714
anti-S-100 antibody -LRB- 1:500 dilution -RRB- , anti-β-III tubulin antibody -LRB- 1:1,000 dilution -RRB- , and anti-nestin polyclonal antibody -LRB- 1:1,000 dilution ; all from Gibco , Grand Island , NY , USA -RRB-	9748
anti-S-100 antibody -LRB- 1:500 dilution -RRB-	9748
anti-S-100 antibody	9748
1:500 dilution	9769
anti-β-III tubulin antibody -LRB- 1:1,000 dilution -RRB-	9786
anti-β-III tubulin antibody	9786
1:1,000 dilution	9815
anti-nestin polyclonal antibody -LRB- 1:1,000 dilution ; all from Gibco , Grand Island , NY , USA -RRB-	9838
anti-nestin polyclonal antibody	9838
1:1,000 dilution ; all from Gibco	9871
1:1,000 dilution	9871
all from Gibco	9889
all	9889
Gibco	9898
Grand Island , NY , USA	9905
Grand Island	9905
NY , USA	9919
overnight	9928
4 °C	9941
The slides	9947
PBS	9973
three times	9977
fluorescein-conjugate affinipure -LRB- FITC -RRB-	10008
fluorescein-conjugate affinipure	10008
FITC	10042
goat anti-rabbit IgG -LRB- 1:100 dilution -RRB- for 2 h at 37 °C	10048
goat anti-rabbit IgG -LRB- 1:100 dilution -RRB-	10048
goat anti-rabbit IgG	10048
1:100 dilution	10070
2 h at 37 °C	10090
2 h	10090
37 °C	10097
repeat washing with PBS	10110
repeat	10110
PBS	10130
the slides	10135
Hoechst 33342 -LRB- 1:100 dilution ; all from Boster , Wuhan , China -RRB- for 30 min	10166
Hoechst 33342 -LRB- 1:100 dilution ; all from Boster , Wuhan , China -RRB-	10166
Hoechst 33342	10166
1:100 dilution ; all from Boster	10181
1:100 dilution	10181
all from Boster	10197
all	10197
Boster	10206
Wuhan , China	10214
Wuhan	10214
China	10221
30 min	10232
37 °C	10242
Gel / Mount aqueous mounting media	10270
Mount	10275
media	10298
The sections	10305
fluorescence microscope -LRB- Olympus BX50 , JPN -RRB-	10338
fluorescence microscope	10338
Olympus BX50	10363
JPN	10377
the distribution area , the migration distances and the number of fluorescence cells	10397
the distribution area	10397
the migration distances	10420
the number of fluorescence cells	10448
the number	10448
fluorescence cells	10462
images	10482
× 20	10515
Olympus BX50 light microscope from every fifth section	10525
Olympus BX50 light microscope	10525
every fifth section	10560
a total of five sections from each animal	10585
a total	10585
five sections from each animal	10596
five sections	10596
each animal	10615
Adobe Photoshop 10.0	10645
Spot 345 software	10682
Quantitative Real-Time Polymerase Chain Reaction	10701
the mRNA sequence of GDNF and BDNF -LRB- http://www.ncbi.nlm.nih.gov/genbank -RRB-	10763
the mRNA sequence	10763
GDNF and BDNF -LRB- http://www.ncbi.nlm.nih.gov/genbank -RRB-	10784
GDNF and BDNF	10784
http://www.ncbi.nlm.nih.gov/genbank	10799
the primers -LRB- Table 1 -RRB-	10837
the primers	10837
Table 1	10850
the GeneTool software -LRB- Biotools , USA -RRB-	10876
the GeneTool software	10876
Biotools	10899
USA	10909
The spinal cord segments -LRB- about 10 mm -RRB- centered on the injury site	10915
The spinal cord segments -LRB- about 10 mm -RRB-	10915
The spinal cord segments	10915
10 mm	10947
the injury site	10966
3 and 9 weeks after SCI -LRB- n = 5/group/time point -RRB-	10999
3 and 9 weeks	10999
SCI -LRB- n = 5/group/time point -RRB-	11019
SCI	11019
n = 5/group/time point	11024
n	11024
= 5/group/time point	11025
They	11047
TRIzol reagent and DNaseI -LRB- all from Invitrogen , Carlsbad , CA , USA -RRB-	11072
TRIzol reagent and DNaseI	11072
all from Invitrogen , Carlsbad , CA ,	11099
all	11099
Invitrogen , Carlsbad , CA ,	11108
USA	11134
First strand complementary DNA -LRB- cDNA -RRB-	11140
First strand complementary DNA	11140
cDNA	11172
the Rever Tre Ace-a-reverse transcription kit -LRB- Toyobo , JPN -RRB-	11200
the Rever Tre Ace-a-reverse transcription kit	11200
Toyobo	11247
JPN	11255
manufacturer 's instructions	11273
manufacturer 's	11273
quantitative PCR -LRB- qPCR -RRB-	11306
quantitative PCR	11306
qPCR	11324
20 μl reactions	11331
10 μl	11360
2 × SYBR Green , 2 μl cDNA template , and 0.5 μl RT-qPCR Primer Set were used	11366
2 × SYBR Green	11366
2 ×	11366
SYBR Green	11369
2 μl cDNA template	11381
0.5 μl RT-qPCR Primer Set were used	11405
0.5 μl RT-qPCR Primer	11405
Thermo cycling conditions	11442
94 °C for 5 min , 30 cycles of 94 °C for 30 s , 55 °C for 30 s , 72 °C for 30 s , and 72 °C for 10 min	11485
94 °C for 5 min	11485
94 °C	11485
5 min	11495
30 cycles of 94 °C for 30 s	11502
30 cycles	11502
94 °C for 30 s	11515
94 °C	11515
30 s	11525
55 °C for 30 s	11531
55 °C	11531
30 s	11541
72 °C for 30 s	11547
72 °C	11547
30 s	11557
72 °C for 10 min	11567
72 °C	11567
10 min	11577
curve analysis	11593
a single amplification peak	11615
each reaction	11647
Ct values for targets	11662
Ct values	11662
targets	11676
relative expression	11702
the average of housekeeping genes -LRB- β-actin -RRB-	11734
the average	11734
housekeeping genes -LRB- β-actin -RRB-	11749
housekeeping genes	11749
β-actin	11769
Immunohistochemical Staining of BDNF and GDNF The frozen slides were air	11779
Immunohistochemical Staining	11779
BDNF and GDNF	11811
The frozen slides	11825
air	11848
room temperature	11861
10 min	11882
PBS for 10 min	11905
PBS	11905
10 min	11913
n = 5/group	11921
n	11921
= 5/group	11922
time point	11932
time	11932
point	11937
The sections	11945
0.3 % Triton X-100 / 10 %	11994
0.3 % Triton X-100	11994
10 %	12013
normal goat serum in 0.01 M PBS for 30 min	12018
normal goat serum	12018
0.01 M PBS for 30 min	12039
0.01 M PBS	12039
30 min	12054
polyclonal rabbit antibodies	12082
anti-BDNF -LRB- 1:500 dilution -RRB- and anti-GDNF -LRB- 1:500 dilution -RRB- overnight at 4 °C	12111
anti-BDNF -LRB- 1:500 dilution -RRB- and anti-GDNF -LRB- 1:500 dilution -RRB- overnight	12111
1:500 dilution	12122
1:500 dilution	12153
4 °C	12182
The sections	12188
secondary biotinylated goat anti-rabbit IgG antibody -LRB- 1:1,000 dilution ; Abcam , Cambridge , MA , USA -RRB- for 1 h at room temperature , followed by an avidin -- biotin -- peroxidase complex -LRB- ABC kit , Thermo Fisher Scientific , Rockford , IL , USA -RRB-	12221
secondary	12221
goat anti-rabbit IgG antibody -LRB- 1:1,000 dilution ; Abcam , Cambridge , MA , USA -RRB-	12244
goat anti-rabbit IgG antibody	12244
goat	12244
anti-rabbit IgG antibody	12249
1:1,000 dilution ; Abcam , Cambridge , MA , USA	12275
1:1,000 dilution	12275
Abcam , Cambridge , MA , USA	12293
1 h at room temperature	12324
1 h	12324
room temperature	12331
an avidin -- biotin -- peroxidase complex -LRB- ABC kit , Thermo Fisher Scientific , Rockford , IL , USA -RRB-	12361
an avidin -- biotin -- peroxidase complex	12361
avidin -- biotin --	12364
avidin	12364
biotin	12371
ABC kit , Thermo Fisher Scientific , Rockford , IL , USA	12398
ABC kit	12398
Thermo Fisher Scientific	12407
Rockford	12433
IL	12443
USA	12447
incubation for 5 min with 0.02 % DAB -LRB- Boster , Wuhan , China -RRB- and 0.003 % H2O2	12459
incubation	12459
5 min with 0.02 % DAB -LRB- Boster , Wuhan , China -RRB- and 0.003 % H2O2	12474
5 min with 0.02 % DAB -LRB- Boster , Wuhan , China -RRB-	12474
5 min	12474
0.02 % DAB -LRB- Boster , Wuhan , China -RRB-	12485
0.02 % DAB	12485
Boster	12497
Wuhan	12505
China	12512
0.003 % H2O2	12523
0.003 %	12523
H2O2	12531
the sections	12537
hematoxylin	12575
Primary antibody omission controls	12588
order	12636
the specificity of the immunohistochemical labeling	12653
the specificity	12653
the immunohistochemical labeling	12672
The sections	12706
light microscope	12739
digital images	12762
× 40	12800
every fifth section in total of five sections	12809
every fifth section	12809
total of five sections	12832
total	12832
five sections	12841
each animal	12860
The positive area of BDNF and GDNF	12873
The positive area	12873
BDNF and GDNF	12894
Spot 345 software	12926
that of the blank control group	12962
that	12962
the blank control group	12970
The percentage of the positive area in each group to blank control group	12995
The percentage	12995
the positive area in each group to blank control group	13013
the positive area	13013
each group to blank control group	13034
each group	13034
blank control group	13048
Assessment of Locomotor Behavior The locomotor behavior of each rat	13084
Assessment	13084
Locomotor Behavior The locomotor behavior of each rat	13098
Locomotor Behavior The locomotor behavior	13098
each rat	13143
9 weeks	13178
transplantation	13192
the Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- hindlimb locomotor rating scale -LRB- n = 10/group -RRB- -LRB- Basso et al. 1995 -RRB-	13214
the Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- hindlimb locomotor rating scale -LRB- n = 10/group -RRB-	13214
the Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- hindlimb locomotor rating scale	13214
Basso -- Beattie -- Bresnahan -LRB- BBB -RRB- hindlimb	13218
Basso -- Beattie -- Bresnahan -LRB- BBB -RRB-	13218
Basso -- Beattie -- Bresnahan	13218
Beattie	13225
BBB	13244
n	13282
10/group	13284
Basso	13295
et al. 1995	13301
et al.	13301
1995	13308
The BBB rating scale	13315
a 21-point system based on operationally defined behavioral features that follow the recovery progression from complete paralysis to normal locomotion	13339
a 21-point system	13339
operationally defined behavioral features	13366
the recovery progression	13420
complete paralysis to normal locomotion	13450
complete paralysis	13450
normal locomotion	13472
The rating scale	13491
0 to 21 , in which score 0 indicates complete hindlimb paralysis , while score 21 denotes completely normal locomotor function	13520
0 to 21	13520
score 0	13538
complete hindlimb paralysis	13556
score 21	13591
completely normal locomotor function	13608
Scores of 1 -- 20 indicate an animal 's altered ability to move the hindlimb joints , to bear weight , and to coordinate forelimb and hindlimb movement .	13646
Scores of 1	13646
Scores	13646
1	13656
20 indicate an animal 's altered ability to move the hindlimb joints , to bear weight , and to coordinate forelimb and hindlimb movement	13658
20	13658
an animal 's altered ability to move the hindlimb joints , to bear weight , and to coordinate forelimb and hindlimb movement	13670
an animal 's	13670
the hindlimb joints	13706
weight	13735
forelimb and hindlimb movement	13761
Statistical Analysis All values	13793
Statistical Analysis	13793
All values	13814
mean ± standard deviation -LRB- SD -RRB-	13842
mean ± standard deviation	13842
SD	13867
Differences between groups	13872
Differences	13872
groups	13892
statistical significance using one-way factorial analysis of variance -LRB- ANOVA -RRB-	13917
statistical significance	13917
one-way factorial analysis of variance -LRB- ANOVA -RRB-	13948
one-way factorial analysis	13948
variance -LRB- ANOVA -RRB-	13978
variance	13978
ANOVA	13988
A p	13996
0.05 denoted the presence of a significant difference	14007
0.05	14007
the presence of a significant difference	14020
the presence	14020
a significant difference	14036
The above tests	14062
SPSS software version	14099
11.0 -LRB- SPSS Inc. , Chicago , IL , USA -RRB-	14121
11.0	14121
SPSS Inc. , Chicago , IL , USA	14127
SPSS Inc.	14127
Chicago	14138
IL	14147
USA	14151
Results Table 1 Primers sets for qPCR Fig. 1 At 3 weeks posttransplantation , migration and distribution of EPINCSCs and OECs in the	14158
Results	14158
Table	14166
1 Primers sets for qPCR Fig. 1 At 3 weeks posttransplantation , migration and distribution of EPINCSCs and OECs in the	14172
1 Primers sets	14172
qPCR Fig. 1 At 3 weeks posttransplantation , migration and distribution of EPINCSCs and OECs in the	14191
qPCR Fig. 1 At 3 weeks	14191
qPCR Fig.	14191
1 At 3 weeks	14202
posttransplantation , migration and distribution of EPINCSCs	14215
posttransplantation , migration and distribution	14215
EPINCSCs	14266
OECs in the	14279
OECs	14279
the	14287
cord on the longitudinal frozen sections	14300
cord	14300
the longitudinal frozen sections	14308
a EPI-NCSCs group .	14342
b OECs group .	14361
b OECs	14361
group	14368
c co-transplantation group .	14375
c	14375
co-transplantation group	14377
A1 -- C3 were higher magnification of boxed area in a --	14403
A1	14403
C3	14406
higher magnification of boxed area	14414
higher magnification	14414
boxed area	14438
A1	14457
C1	14460
GFP + graft cells	14470
GFP	14470
graft cells	14475
A2 -- C2 indicated nuclei stained by Hoechst 33342 .	14488
A2	14488
C2	14491
nuclei stained by Hoechst 33342	14504
nuclei	14504
Hoechst 33342	14522
A3 -- C3 were merged pictures of GFP + and Hoechst 33342 + .	14537
A3	14537
C3	14541
pictures of GFP	14556
pictures	14556
GFP	14568
+	14571
Hoechst 33342	14577
+	14590
d Semiquantification of distribution area , migration distance , and number of graft cells .	14593
d Semiquantification	14593
distribution area , migration distance , and number	14617
distribution area	14617
migration distance	14636
number	14660
graft cells	14670
Scale	14683
a -- c = 200 μm , A1 -- C3	14694
c = 200 μm , A1	14696
c =	14696
200 μm	14698
A1	14706
= 50 μm Fig. 2 Immunofluorescence staining showing differences in expression of β-III tubulin , nestin and S-100 at 3 weeks post-co-transplantation in the injured spinal cord -LRB- n = 3/group -RRB-	14711
= 50 μm Fig. 2 Immunofluorescence staining	14711
differences in expression of β-III tubulin , nestin and S-100	14762
differences	14762
expression of β-III tubulin , nestin and S-100	14777
expression	14777
β-III tubulin , nestin and S-100	14791
β-III tubulin	14791
nestin	14806
S-100	14817
3 weeks post-co-transplantation in the injured spinal cord -LRB- n = 3/group -RRB-	14826
3 weeks post-co-transplantation	14826
the injured spinal cord -LRB- n = 3/group -RRB-	14861
the injured spinal cord	14861
n = 3/group	14886
n	14886
= 3/group	14887
Arrows	14898
areas of high positive expression	14914
areas	14914
high positive expression	14923
Scale bars	14949
100 μm Fig. 3 Comparison of BDNF and GDNF expression among the different treatment groups quantified with the qPCR analysis	14960
100 μm Fig.	14960
3 Comparison of BDNF and GDNF expression among the different treatment groups	14973
3 Comparison	14973
BDNF and GDNF expression among the different treatment groups	14989
BDNF and GDNF expression	14989
the different treatment groups	15020
the qPCR analysis	15067
3 and 9 weeks after transplantation	15088
3 and 9 weeks	15088
transplantation	15108
p <	15126
p	15126
<	15127
0.05 Fig.	15128
4 Immunohistochemical staining of BDNF and GDNF	15139
4 Immunohistochemical staining	15139
BDNF and GDNF	15173
3 and 9 weeks after transplantation	15190
3 and 9 weeks	15190
transplantation	15210
-LRB- Column A -RRB- BDNF	15227
Column A	15228
3 weeks	15246
-LRB- Column B -RRB- BDNF	15255
Column B	15256
9 weeks	15274
-LRB- Column C -RRB- GDNF	15283
Column C	15284
3 weeks	15302
-LRB- Column D -RRB- GDNF	15311
Column D	15312
9 weeks	15330
A1	15340
D1 -RRB- the blank control	15343
D1	15343
the blank control	15347
-LRB- A2 -- D2 -RRB-	15366
A2 -- D2	15367
A2	15367
D2	15370
-LRB- A3 -- D3 -RRB-	15384
A3 -- D3	15385
A3	15385
D3	15388
-LRB- A4 -- D4 -RRB-	15404
A4 -- D4	15405
A4	15405
D4	15408
A5	15419
D5 -RRB- the co-transplantation	15422
D5	15422
the co-transplantation	15426
-LRB- E -RRB- Semiquantification of BDNF .	15450
-LRB- E -RRB-	15450
Semiquantification of BDNF	15454
Semiquantification	15454
BDNF	15476
-LRB- F -RRB- Semi-quantification of GDNF .	15482
-LRB- F -RRB-	15482
Semi-quantification of GDNF	15486
Semi-quantification	15486
GDNF	15509
Scale bars	15515
100 μm Survival , Migration , and Distribution of OECs and EPI-NCSCs Representative longitudinal sections showed the survival , migration , and distribution of grafted GFP + cells in the contused spinal cord -LRB- Fig. 1 -RRB-	15527
100 μm Survival	15527
Migration	15545
Distribution of OECs and EPI-NCSCs Representative longitudinal sections showed the survival , migration , and distribution of grafted GFP + cells in the contused spinal cord -LRB- Fig. 1 -RRB-	15560
Distribution of OECs and EPI-NCSCs Representative longitudinal sections showed the survival , migration , and distribution of grafted GFP	15560
Distribution	15560
OECs and EPI-NCSCs	15576
Representative longitudinal sections	15595
the survival , migration , and distribution of grafted GFP	15639
the survival , migration , and distribution	15639
grafted GFP	15684
cells in the contused spinal cord -LRB- Fig. 1 -RRB-	15697
cells	15697
the contused spinal cord -LRB- Fig. 1 -RRB-	15706
the	15706
spinal cord -LRB- Fig. 1 -RRB-	15719
spinal cord	15719
Fig. 1	15732
3 weeks after transplantation	15744
3 weeks	15744
transplantation	15758
the green donor cells	15775
masses at injection site	15809
masses	15809
injection site	15819
EPI-NCSCsinjected group	15837
migration	15870
the boundary of graft EPI-NCSCs	15885
the boundary	15885
graft EPI-NCSCs	15901
the surrounding tissue -LRB- Fig. 1a -RRB-	15932
the surrounding tissue	15932
Fig. 1a	15956
OECs-injected group	15970
the donor cells	15991
the host tissue	16045
Fig. 1b	16086
co-injected group	16100
the mixed donor cells	16119
injection site	16155
the longitudinal axis of the host cord	16176
the longitudinal axis	16176
the host cord	16201
cell beam between the injection sites	16226
cell beam	16226
the injection sites	16244
the injured area -LRB- Fig. 1c -RRB-	16277
the injured area	16277
Fig. 1c	16295
Semi-quantification data	16305
3 weeks	16345
the distribution area	16354
0.342 ± 0.057 mm2	16380
0.342	16380
0.057 mm2	16386
the migration distance of 0.399 ± 0.071 mm in the EPI-NCSCs group , which was significantly different from 0.626 ± 0.124 mm2 and 1.710 ± 0.223 mm in the OECs group and 0.636 ± 0.182 mm2 and 1.816 ± 0.563 mm in the co-transplantation group -LRB- p < 0.05 -RRB-	16401
the migration distance	16401
0.399 ± 0.071 mm in the EPI-NCSCs group , which was significantly different from 0.626 ± 0.124 mm2 and 1.710 ± 0.223 mm in the OECs group and 0.636 ± 0.182 mm2 and 1.816 ± 0.563 mm in the co-transplantation group -LRB- p < 0.05 -RRB-	16427
0.399 ±	16427
0.071 mm in the EPI-NCSCs group , which was significantly different from 0.626 ± 0.124 mm2 and 1.710 ± 0.223 mm in the OECs group and 0.636 ± 0.182 mm2 and 1.816	16433
0.071 mm	16433
the EPI-NCSCs group , which was significantly different from 0.626 ± 0.124 mm2 and 1.710 ± 0.223 mm in the OECs group and 0.636 ± 0.182 mm2 and 1.816	16445
the EPI-NCSCs group	16445
0.626 ± 0.124 mm2 and 1.710 ± 0.223 mm	16505
0.626 ± 0.124 mm2	16505
0.626 ±	16505
0.124 mm2	16511
1.710 ± 0.223 mm	16525
1.710	16525
0.223 mm	16531
the OECs group and 0.636 ± 0.182 mm2 and 1.816	16543
the OECs group	16543
0.636 ± 0.182 mm2 and 1.816	16562
0.636 ± 0.182 mm2	16562
0.636	16562
0.182 mm2	16569
1.816	16583
0.563 mm	16589
the co-transplantation group -LRB- p < 0.05 -RRB-	16601
the co-transplantation group	16601
p < 0.05	16631
p	16631
< 0.05	16632
<	16632
0.05	16633
9 weeks	16643
the number of survival green fluorescence cells	16658
the number	16658
survival green fluorescence cells	16672
each group	16733
even no survival green fluorescence cells	16745
the EPI-NCSCs group	16808
the distribution area and migration distance	16829
OECs and co	16896
transplantation group	16909
The results	16932
the area and the distance	16959
the area	16959
the distance	16972
0.497 ± 0.082 mm2 and 2.004 ± 0.479 mm	16990
0.497 ± 0.082 mm2	16990
0.497	16990
0.082 mm2	16996
2.004 ± 0.479 mm	17010
2.004	17010
0.479 mm	17016
the OECs group and 0.016 ± 0.012 mm2 and 0.301 ± 0.147 mm	17028
the OECs group	17028
0.016 ± 0.012 mm2 and 0.301 ± 0.147 mm	17047
0.016 ± 0.012 mm2	17047
0.016	17047
0.012 mm2	17053
0.301 ± 0.147 mm	17067
0.301	17067
0.147 mm	17073
the co-transplantation group	17085
The number of graft cells	17115
The number	17115
graft cells	17129
co-transplantation group than inOECs group	17153
co-transplantation group	17153
inOECs group	17183
EPI-NCSCs group	17213
3 weeks	17232
EPI-NCSCs	17249
β-III tubulin and nestin -LRB- Hu et al. 2006 ; Sieber-Blum and Hu 2008 -RRB-	17277
β-III tubulin and nestin	17277
Hu et al. 2006 ; Sieber-Blum and Hu 2008	17303
Hu	17303
et al. 2006 ; Sieber-Blum and Hu 2008	17306
et al. 2006	17306
et al.	17306
2006	17313
Sieber-Blum and Hu 2008	17319
Sieber-Blum	17319
Hu 2008	17335
OECs	17354
S-100 -LRB- Sasaki et al. 2004 -RRB- , at 3 weeks	17377
S-100 -LRB- Sasaki et al. 2004 -RRB-	17377
S-100	17377
Sasaki	17384
et al. 2004	17391
et al.	17391
2004	17398
3 weeks	17408
the sections	17417
β-III tubulin	17453
+	17466
GFP + , nestin	17468
GFP +	17468
GFP	17468
+	17471
nestin	17474
+	17480
GFP + , or S-100 − / GFP + for	17482
GFP +	17482
GFP	17482
+	17485
S-100 − / GFP + for	17491
S-100 −	17491
GFP + for	17498
GFP	17498
for	17503
EPI-NCSCs	17519
β-III tubulin	17533
− / GFP + , nestin − / GFP + , or S-100	17546
− / GFP + , nestin − / GFP + ,	17546
−	17546
GFP + , nestin − / GFP	17548
GFP +	17548
GFP	17548
+	17551
nestin − / GFP	17554
nestin −	17554
GFP	17562
+	17565
S-100	17571
GFP + for	17578
GFP	17578
for	17583
OECs	17595
The cells count	17601
the proportion of EPI-NCSCs	17629
the proportion	17629
EPI-NCSCs	17647
37.9 ± 9.2 %	17661
37.9	17661
9.2 %	17666
the others	17677
OECs -LRB- Fig. 2 -RRB-	17693
OECs	17693
Fig. 2	17699
Expression of BDNF and GDNF qPCR -LRB- Fig. 3 -RRB- and immunoassaying -LRB- Fig. 4 -RRB-	17708
Expression	17708
BDNF and GDNF qPCR -LRB- Fig. 3 -RRB- and immunoassaying -LRB- Fig. 4 -RRB-	17722
BDNF and GDNF qPCR	17722
Fig. 3	17742
immunoassaying	17754
Fig. 4	17770
the effects of the donor cells	17805
the effects	17805
the donor cells	17820
the expression of BDNF and GDNF	17839
the expression	17839
BDNF and GDNF	17857
molecular and protein levels in the injured cord	17874
molecular and protein levels	17874
the injured cord	17906
the co-transplanted group	17927
the expression of BDNF and GDNF at both levels	17954
the expression	17954
BDNF and GDNF	17972
both levels	17989
the control group and individual cell transplantation group at 3 weeks posttransplantation -LRB- p < 0.05 -RRB-	18040
the control group	18040
individual cell transplantation group at 3 weeks posttransplantation -LRB- p < 0.05 -RRB-	18062
individual cell transplantation group	18062
3 weeks posttransplantation -LRB- p < 0.05 -RRB-	18103
3 weeks posttransplantation	18103
3 weeks	18103
posttransplantation	18111
p < 0.05	18132
p	18132
< 0.05	18133
<	18133
0.05	18134
the expression of both factors in cotransplantation group	18150
the expression	18150
both factors in cotransplantation group	18168
both factors	18168
cotransplantation group	18184
9 weeks	18226
3 weeks	18248
There	18257
no statistical difference among cell transplantation groups at 9 weeks posttransplantation -LRB- p > 0.05 -RRB-	18267
no statistical difference	18267
cell transplantation groups at 9 weeks posttransplantation -LRB- p > 0.05 -RRB-	18299
cell transplantation groups at 9 weeks posttransplantation	18299
cell transplantation groups	18299
9 weeks	18330
p > 0.05	18359
p	18359
> 0.05	18360
>	18360
0.05	18361
Locomotor BBB Scores All animals	18368
Locomotor BBB Scores	18368
All animals	18389
gradual improvements	18411
hind limb locomotor function	18435
the 9-week recovery period	18471
The best BBB scores	18499
The best	18499
BBB scores	18508
the co-injected animals , then orderly from the OECs - and EPI-NCSCs-injected animals	18533
the OECs	18576
BBB scores for cell-injected rats	18618
BBB scores	18618
cell-injected rats	18633
significantly from the controls at p <	18661
the controls at p	18680
the controls	18680
p	18696
0.01	18698
p	18706
early and late weeks -LRB- Fig. 5 -RRB-	18717
early and late weeks	18717
Fig. 5	18739
Discussion	18749
It	18760
SCI	18784
a series of pathophysiological changes including apoptosis and nerve cells loss -LRB- Rodriguez-Barrera et al. 2013 -RRB-	18802
a series	18802
pathophysiological changes including apoptosis and nerve cells loss -LRB- Rodriguez-Barrera et al. 2013 -RRB-	18814
pathophysiological changes	18814
apoptosis and nerve cells loss	18851
Rodriguez-Barrera	18883
et al. 2013	18901
et al.	18901
2013	18908
recent years	18918
cell transplantation for treating SCI	18932
cell transplantation	18932
SCI	18966
an interesting subject , in which the transplanted cells modulating microenvironment for axon regeneration by secreting neurotrophic factors -LRB- NTFs -RRB- is one of major mechanisms -LRB- Rich 1992 ; Zhao et al. 2004 -RRB-	18979
an interesting subject	18979
the transplanted cells modulating microenvironment for axon regeneration by secreting neurotrophic factors -LRB- NTFs -RRB-	19012
the transplanted cells	19012
microenvironment for axon regeneration	19046
microenvironment	19046
axon regeneration	19067
neurotrophic factors -LRB- NTFs -RRB-	19098
neurotrophic factors	19098
NTFs	19120
one of major mechanisms -LRB- Rich 1992 ; Zhao et al. 2004 -RRB-	19129
one	19129
major mechanisms -LRB- Rich 1992 ; Zhao et al. 2004 -RRB-	19136
major mechanisms	19136
Rich 1992 ; Zhao et al. 2004	19154
Rich 1992 ; Zhao et al.	19154
Rich 1992	19154
1992	19159
Zhao et al.	19165
Zhao	19165
et al.	19170
2004	19177
EPI-NCSCs replacement	19184
a promising strategy for SCI repair	19213
a promising strategy	19213
SCI repair	19238
the poor migration of grafted EPINCSCs in the injured cord	19259
the poor migration	19259
grafted EPINCSCs in the injured cord	19281
grafted EPINCSCs	19281
the injured cord	19301
a major challenge , which limits its use as a donor cell for the repair of SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19326
a major challenge	19326
its use	19358
a donor cell for the repair of SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19369
a donor cell	19369
the repair of SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19386
the repair	19386
SCI -LRB- Sieber-Blum et al. 2006 -RRB-	19400
SCI	19400
Sieber-Blum	19405
et al. 2006	19417
et al.	19417
2006	19424
Cell migration	19431
a fundamental process during the repair of SCI	19449
a fundamental process	19449
the repair of SCI	19478
the repair	19478
SCI	19492
grafted cells	19505
sites that differ fromthose in which they eventually reside -LRB- Liu and Rao 2003 -RRB-	19543
sites	19543
fromthose in which they eventually reside	19561
fromthose	19561
they	19580
Liu and Rao 2003	19604
Liu	19604
Rao 2003	19612
strategies aimed at enhancing the migration of grafted EPI-NCSCs	19629
strategies	19629
the migration of grafted EPI-NCSCs	19659
the migration	19659
grafted EPI-NCSCs	19676
It	19720
OECs	19754
and secret many growth factors and chemotactic factors	19767
secret many growth factors and chemotactic factors	19771
secret many growth factors	19771
chemotactic factors	19802
GDNF , NGF , BDNF , and CNTF -LRB- Woodhall et al. 2001 ; Yin et al. 2013 -RRB-	19833
GDNF	19833
NGF	19839
BDNF	19844
CNTF -LRB- Woodhall et al. 2001 ; Yin et al. 2013 -RRB-	19854
CNTF	19854
Woodhall	19860
et al. 2001 ; Yin et al. 2013	19869
et al. 2001 ; Yin et al.	19869
et al. 2001	19869
et al.	19869
2001	19876
Yin et al.	19882
Yin	19882
et al.	19886
2013	19893
These secreted factors	19900
These	19900
factors	19915
the growth and the migration of EPI-NCSCs -LRB- Sadan et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al. 2014 -RRB-	19943
the growth	19943
the migration of EPI-NCSCs -LRB- Sadan et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al. 2014 -RRB-	19958
the migration	19958
EPI-NCSCs -LRB- Sadan et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al. 2014 -RRB-	19975
EPI-NCSCs	19975
Sadan	19986
et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al. 2014	19992
et al. 2008 ; Cornejo et al. 2014 ; Rosenblum et al.	19992
et al. 2008	19992
et al.	19992
2008	19999
Cornejo et al. 2014	20005
Cornejo	20005
et al.	20013
2014	20020
Rosenblum et al.	20026
Rosenblum	20026
et al.	20036
2014	20043
this study	20060
EPINCSCs and OECs	20072
the contused spinal cord at 1 week after injury , showing that the ability of migration of EPI-NCSCs in vivo was enhanced when transplanted with OECs together	20116
the	20116
spinal cord	20129
1 week after injury	20144
1 week	20144
injury	20157
the ability of migration of EPI-NCSCs in vivo	20178
the ability	20178
migration of EPI-NCSCs in vivo	20193
migration	20193
EPI-NCSCs in vivo	20206
EPI-NCSCs	20206
vivo	20219
OECs	20260
The expression of BDNF and GDNF	20275
The expression	20275
BDNF and GDNF	20293
the synergism of both grafted cells	20335
the synergism	20335
both grafted cells	20352
co-transplantation of EPI-NCSCs and OECs	20385
co-transplantation	20385
EPI-NCSCs and OECs	20407
functional recovery	20435
SCI	20461
the present study	20469
it	20488
OECs	20538
the migratory distance and distribution area of EPI-NCSCs in vivo , but not survival time	20567
the migratory distance and distribution area	20567
EPI-NCSCs in vivo , but not survival time	20615
EPI-NCSCs in vivo	20615
EPI-NCSCs	20615
vivo	20628
survival time	20642
it	20669
the migratory process	20695
various factors	20735
BDNF/GDNF	20756
a promising candidate -LRB- Mitsuhara et al. 2013 -RRB-	20776
a promising candidate	20776
Mitsuhara	20799
et al. 2013	20809
et al.	20809
2013	20816
Both factors	20823
an important role in migration of neural stem cells via the manner of timedependent -LRB- Hwang et al. 2009 -RRB-	20841
an important role	20841
migration of neural stem cells via the manner of timedependent -LRB- Hwang et al. 2009 -RRB-	20862
migration	20862
neural stem cells via the manner of timedependent -LRB- Hwang et al. 2009 -RRB-	20875
neural stem cells	20875
the manner of timedependent -LRB- Hwang et al. 2009 -RRB-	20897
the manner	20897
timedependent -LRB- Hwang et al. 2009 -RRB-	20911
timedependent	20911
Hwang	20926
et al. 2009	20932
et al.	20932
2009	20939
GDNF receptors	20946
the migratory pathway -LRB- Paratcha et al. 2003 -RRB-	20981
the migratory pathway	20981
Paratcha et al. 2003	21004
Paratcha	21004
et al. 2003	21013
et al.	21013
2003	21020
qPCR assay and immunohistochemical staining	21030
qPCR assay	21030
immunohistochemical staining	21045
we	21075
the expression of BDNF and GDNF at both molecular and protein levels	21089
the expression	21089
BDNF and GDNF	21107
both molecular and protein levels	21124
the cotransplantation	21175
migratory distance of EPI-NCSCs	21214
migratory distance	21214
EPI-NCSCs	21236
itself transplantation alone	21269
the mechanism of BDNF and GDNF promoting EPI-NCSCs to migrate	21309
the mechanism	21309
BDNF and GDNF	21326
EPI-NCSCs	21350
it	21372
this study	21397
It	21409
neurotrophic factors	21430
an external signal membrane surface recipient to intracellular	21464
an external signal membrane surface	21464
pseudopodia in a particular direction	21539
pseudopodia	21539
a particular direction	21554
movement -LRB- Mitsuhara et al. 2013 -RRB-	21580
movement	21580
Mitsuhara	21590
et al. 2013	21600
et al.	21600
2013	21607
the direction of the concentration gradient of NTFs	21627
the direction	21627
the concentration gradient of NTFs	21644
the concentration gradient	21644
NTFs	21674
the cell migration -LRB- Paratcha et al. 2006 -RRB-	21702
the cell migration	21702
Paratcha et al. 2006	21722
Paratcha	21722
et al. 2006	21731
et al.	21731
2006	21738
BDNF and GDNF	21745
these effects via two main signaling receptors , the tyrosine-kinase receptor trkB and the neural cell adhesion molecule -LRB- NCAM -RRB- -LRB- Kaplan and Miller 2000 ; Paratcha and Ledda 2008 -RRB-	21767
these effects	21767
two main signaling receptors , the tyrosine-kinase receptor trkB and the neural cell adhesion molecule -LRB- NCAM -RRB- -LRB- Kaplan and Miller 2000 ; Paratcha and Ledda 2008 -RRB-	21785
two main signaling receptors , the tyrosine-kinase receptor trkB and the neural cell adhesion molecule -LRB- NCAM -RRB-	21785
two main signaling receptors , the tyrosine-kinase receptor trkB and the neural cell adhesion molecule	21785
two main signaling receptors	21785
the tyrosine-kinase receptor trkB	21815
the neural cell adhesion molecule	21853
NCAM	21888
Kaplan and Miller	21895
2000 ; Paratcha and Ledda 2008	21913
2000	21913
Paratcha and Ledda 2008	21919
Paratcha	21919
Ledda 2008	21932
It	21945
NCAM	21962
these ligand -- receptor interactions -LRB- Rutishauser 2008 -RRB-	21978
these ligand	21978
receptor interactions -LRB- Rutishauser 2008 -RRB-	21991
receptor interactions	21991
Rutishauser 2008	22014
fact	22036
NCAM	22042
the interaction of NTFs with trkB -LRB- Muller et al. 2000 ; Vutskits et al. 2001 -RRB-	22076
the interaction	22076
NTFs with trkB -LRB- Muller et al. 2000 ; Vutskits et al. 2001 -RRB-	22095
NTFs	22095
trkB -LRB- Muller et al. 2000 ; Vutskits et al. 2001 -RRB-	22105
trkB	22105
Muller	22111
et al. 2000 ; Vutskits et al. 2001	22118
et al. 2000 ; Vutskits et al.	22118
et al. 2000	22118
et al.	22118
2000	22125
Vutskits et al.	22131
Vutskits	22131
et al.	22140
2001	22147
the expression of p75 -LRB- Gascon et al. 2007 -RRB-	22169
the expression	22169
p75 -LRB- Gascon et al. 2007 -RRB-	22187
p75	22187
Gascon	22192
et al. 2007	22199
et al.	22199
2007	22206
the neuronal sensitivity	22232
the trophin	22260
NCAM	22273
NTFs chemoattractive effect on the migration of enteric and rostral migratory stream neurons , respectively -LRB- Natarajan et al. 2002 ; Paratcha and Ledda 2008 -RRB-	22307
NTFs	22307
the migration of enteric and rostral migratory stream neurons , respectively -LRB- Natarajan et al. 2002 ; Paratcha and Ledda 2008 -RRB-	22338
the migration of enteric and rostral migratory stream neurons , respectively	22338
the migration of enteric and rostral migratory stream neurons	22338
the migration	22338
enteric and rostral migratory stream neurons	22355
Natarajan et al. 2002 ; Paratcha and Ledda 2008	22415
Natarajan	22415
et al. 2002 ; Paratcha and Ledda 2008	22425
et al. 2002	22425
et al.	22425
2002	22432
Paratcha and Ledda 2008	22438
Paratcha	22438
Ledda 2008	22451
It	22464
that	22490
the expression of BDNF and GDNF	22530
the expression	22530
BDNF and GDNF	22548
the answer	22578
the present data	22614
it	22641
the interaction of OECs and EPI-NCSCs in the contused cord	22666
the interaction	22666
OECs and EPI-NCSCs in the contused cord	22685
OECs and EPI-NCSCs	22685
the contused cord	22707
the	22707
cord	22720
the autocrine and paracrine of NTFs from the donor cells and the host neural elements , eventually	22737
the autocrine and paracrine	22737
NTFs from the donor cells and the host neural elements , eventually	22768
NTFs from the donor cells	22768
NTFs	22768
the donor cells	22778
the host neural elements , eventually	22798
the host	22798
neural elements	22807
higher expression of BDNF and GDNF -LRB- Nicolas et al. 2014 -RRB-	22841
higher expression	22841
BDNF and GDNF -LRB- Nicolas et al. 2014 -RRB-	22862
BDNF and GDNF	22862
Nicolas	22877
et al. 2014	22885
et al.	22885
2014	22892
Previous studies	22899
OECs transplantation	22930
injured spinal cord neurons via the downregulation of semaphorin 3A -LRB- Sema3A -RRB- expression -LRB- Wang et al. 2011 -RRB-	22963
injured spinal cord neurons	22963
the downregulation of semaphorin 3A -LRB- Sema3A -RRB- expression -LRB- Wang et al. 2011 -RRB-	22995
the downregulation	22995
semaphorin 3A -LRB- Sema3A -RRB- expression -LRB- Wang et al. 2011 -RRB-	23017
semaphorin 3A -LRB- Sema3A -RRB- expression	23017
semaphorin 3A -LRB- Sema3A -RRB-	23017
semaphorin 3A	23017
Sema3A	23032
Wang	23052
et al. 2011	23057
et al.	23057
2011	23064
Sema3A	23071
an axon growthmediated factor that has been shown to promote neuronal death and apoptosis , as well as inhibiting axonal regeneration after spinal cord injury via plexinA3 -LRB- Ben-Zvi et al. 2008a , b -RRB-	23081
an axon growthmediated factor that has been shown to promote neuronal death and apoptosis	23081
an axon growthmediated factor	23081
neuronal death and apoptosis	23142
inhibiting axonal regeneration after spinal cord injury via plexinA3 -LRB- Ben-Zvi et al. 2008a , b -RRB-	23183
inhibiting axonal regeneration	23183
spinal cord injury via plexinA3 -LRB- Ben-Zvi et al. 2008a , b -RRB-	23220
spinal cord injury	23220
plexinA3 -LRB- Ben-Zvi et al. 2008a , b -RRB-	23243
plexinA3	23243
Ben-Zvi	23253
et al. 2008a , b	23261
et al. 2008a	23261
b	23275
Sema3A	23288
the secretion of nerve growth factor	23306
the secretion	23306
nerve growth factor	23323
the modulation of the TrkA signaling pathway	23351
the modulation	23351
the TrkA signaling pathway	23369
the growth cone	23420
axonal regeneration -LRB- Ben-Zvi et al. 2008a , b -RRB-	23451
axonal regeneration	23451
Ben-Zvi	23472
et al. 2008a , b	23480
et al. 2008a	23480
b	23494
these speculation	23507
the future study	23548
the present results	23566
synergic effects of the donor cells on their migration and NTFs expression	23601
synergic effects	23601
the donor cells on their migration and NTFs expression	23621
the donor cells	23621
their migration and NTFs expression	23640
BDNF and GDNF	23689
neural regeneration	23721
tissue	23763
functional recovery -LRB- Lang et al. 2013 -RRB-	23780
functional recovery	23780
Lang	23801
et al. 2013	23806
et al.	23806
2013	23813
Both neurotrophic factors	23820
an important regulatory role	23851
neural development , neuron survival , axonal growth , and synaptic remodeling -LRB- Hawryluk et al. 2012 -RRB-	23883
neural development	23883
neuron survival	23903
axonal growth	23920
synaptic remodeling -LRB- Hawryluk et al. 2012 -RRB-	23939
synaptic remodeling	23939
Hawryluk	23960
et al. 2012	23969
et al.	23969
2012	23976
neuronal regeneration	24001
nerve cell degeneration consequently improving structure and function of injured spinal cord	24036
nerve cell degeneration	24036
structure and function of injured spinal cord	24083
structure and function	24083
injured spinal cord	24109
they	24130
acetylcholine and dopamine neurotransmitter release -LRB- Deng et al. 2013 -RRB-	24149
acetylcholine and dopamine neurotransmitter release	24149
Deng	24202
et al. 2013	24207
et al.	24207
2013	24214
The results of qPCR and immunohistochemistry in this study	24221
The results	24221
qPCR and immunohistochemistry in this study	24236
qPCR and immunohistochemistry	24236
this study	24269
the expression of BDNF and GDNF	24294
the expression	24294
BDNF and GDNF	24312
the highest in the co-transplantation group , then orderly the cellinjected and the control groups	24330
the highest	24330
the co-transplantation group , then orderly the cellinjected and the control groups	24345
the co-transplantation group	24345
then orderly the cellinjected and the control groups	24375
then orderly the cellinjected	24375
then orderly the	24375
the control groups	24409
their expression	24438
the co-transplantation group at 9 weeks	24473
the co-transplantation group	24473
9 weeks	24505
3 weeks may caused by the vanishing of EPINCSCs	24525
3 weeks	24525
the vanishing of EPINCSCs	24547
the vanishing	24547
EPINCSCs	24564
the co-injected animals	24574
the best performance recovery , suggesting that function repair can be mediated via the BDNF and GDNF , which could be enhanced by synergic effects of EPI-NCSCs and OECs , rather than only the cell replacement	24602
the best performance recovery	24602
function repair	24649
the BDNF and GDNF	24685
synergic effects of EPI-NCSCs and OECs , rather than only the cell replacement	24731
synergic effects of EPI-NCSCs and OECs	24731
synergic effects	24731
EPI-NCSCs and OECs	24751
only the cell replacement	24783
cell-based therapy of SCI	24814
cell-based therapy	24814
SCI	24836
both active migration of donor cells and adequate NTFs within the injured spinal cord	24841
both active migration of donor cells	24841
both active migration	24841
donor cells	24866
adequate NTFs within the injured spinal cord	24882
adequate NTFs	24882
the injured spinal cord	24903
a permissive environment	24954
neural regeneration	24993
scar formation	25025
necrosis of neurons -LRB- Roloff et al. 2013 -RRB-	25054
necrosis	25054
neurons -LRB- Roloff et al. 2013 -RRB-	25066
neurons	25066
Roloff	25075
et al. 2013	25082
et al.	25082
2013	25089
The nerve degeneration and the neuron death after SCI	25096
The nerve degeneration	25096
the neuron death after SCI	25123
the neuron death	25123
SCI	25146
neurotrophic factors	25168
peripheral target tissue and injured neuron -LRB- Wrathall et al. 1998 -RRB-	25194
peripheral target tissue and injured neuron	25194
Wrathall	25239
et al. 1998	25248
et al.	25248
1998	25255
the axonal transport	25267
survival neurons	25310
neurotrophic factors	25341
NTFs	25363
neural regeneration and functional recovery	25393
neural regeneration	25393
functional recovery	25417
Fouad et al. 2013	25438
Fouad	25438
et al. 2013	25444
et al.	25444
2013	25451
exogenous and endogenous NTFs	25471
the recovery of the structure and the function of injured spinal cord	25502
the recovery	25502
the structure and the function of injured spinal cord	25518
the structure	25518
the function of injured spinal cord	25536
the function	25536
injured spinal cord	25552
Gould and Oppenheim 2004	25589
Gould	25589
Oppenheim 2004	25599
this study	25619
cell migration especially for EPI-NCSCs	25631
cell migration	25631
EPI-NCSCs	25661
higher expression of BDNF and GDNF mediated by synergic effects of the co-transplantation	25687
higher expression	25687
BDNF and GDNF	25708
synergic effects of the co-transplantation	25734
synergic effects	25734
the co-transplantation	25754
motor function of the injured rats	25791
motor function	25791
the injured rats	25809
summary	25843
this study	25852
previous report	25873
neurotrophic factors	25894
the injured spinal cord	25943
it	25977
cotransplantation of OECs and EPI-NCSCs	26010
cotransplantation	26010
OECs and EPI-NCSCs	26031
migration of the donor cells and the expression of BDNF and GDNF	26064
migration of the donor cells	26064
migration	26064
the donor cells	26077
the expression of BDNF and GDNF	26097
the expression	26097
BDNF and GDNF	26115
locomotor recovery of the contused rats	26155
locomotor recovery	26155
the contused rats	26177
